Meeting
2023 ASCO Annual Meeting
ExoLuminate: An observational registry study for detection of pancreatic adenocarcinoma (PDAC) in high-risk or clinically suspicious patients.
Authors
Harmeet Dhani
Biological Dynamics, Inc., San Diego, CA
Harmeet Dhani , Juan Pablo Hinestrosa , Jesus Izaguirre Carbonell , Heath Balcer , Razelle Kurzrock , Paul R. Billings
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Local-Regional Disease
Clinical Trial Registration Number
NCT0562552
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS4203)
DOI
10.1200/JCO.2023.41.16_suppl.TPS4203
Abstract #
TPS4203
Poster Bd #
508a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Large scale proteomics of circulating extracellular vesicles to reveal novel biomarkers for pancreatic cancer.
First Author: Bruno Bockorny
Poster
2023 ASCO Breakthrough
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization.
First Author: Le Son Tran
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The role of Smad4/TGFB signaling in tumorigenesis of pancreatic ductal adenocarcinoma (PDAC).
First Author: Hannah Yoo
Poster
2022 ASCO Annual Meeting
Multicancer early detection with a spectroscopic liquid biopsy platform.
First Author: Matthew Baker